Found 7 matching trials
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants PHASE1 The purpose of this study is to characterize the pharmacokinetic and safety...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant PHASE2 Antibody-mediated rejection (AMR) is a major cause of worsening kidney func...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) PHASE1 The purpose of this study is to evaluate the safety and tolerability of TAK...
Show More Location
Pinnacle Research Group, LLC
Learn More & Join Trial
A Study of TAK-079 in People With Generalized Myasthenia Gravis PHASE2 Myasthenia gravis is an autoimmune condition that causes muscle weakness. A...
Show More Location
The University of Arizona Medical Center
Learn More & Join Trial
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia PHASE3 Primary immune thrombocytopenia (ITP) is a condition where the immune syste...
Show More Location
Genesis Cancer and Blood Institute - SCRI
Learn More & Join Trial
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy PHASE3 Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when ...
Show More Location
UAB Nephrology Research Clinic at Paula Building
Learn More & Join Trial
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia PHASE2 Primary immune thrombocytopenia (ITP) is a rare disease that results in low...
Show More Location
Arizona Clinical Research Center - Hunt - PPDS
Learn More & Join Trial